86017381 - QIAGEN GENEREADER

Information

  • Trademark
  • 86017381
  • Serial Number
    86017381
  • Registration Number
    5075977
  • Filing Date
    July 23, 2013
    11 years ago
  • Registration Date
    November 08, 2016
    8 years ago
  • Transaction Date
    June 27, 2023
    a year ago
  • Status Date
    May 19, 2023
    2 years ago
  • Published for Opposition Date
    August 23, 2016
    8 years ago
  • Location Date
    November 08, 2016
    8 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SINGH, TEJBIR
  • Attorney Docket Number
    133.0505
    Attorney Name
    G MATHEW LOMBARD
    Law Office Assigned Location Code
    L60
  • Owners
Mark Drawing Code
4000
Mark Identification
QIAGEN GENEREADER
Case File Statements
  • GS0091: Scientific apparatuses, instruments and devices and their structural parts and components therefor for analyzing and sequencing biomolecules, namely, nucleic acids; computer software for use in scientific and medical research for assisting in analyzing and sequencing biomolecules, namely, nucleic acids; scientific apparatuses, instruments and devices for analysis of nucleic acids, namely, nucleic acid sequencers
  • GS0051: Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
  • GS0011: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemicals solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
Case File Event Statements
  • 5/19/2023 - 2 years ago
    38 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 11/8/2021 - 3 years ago
    37 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 12/26/2018 - 6 years ago
    36 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 5/30/2018 - 6 years ago
    35 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 8/16/2017 - 7 years ago
    34 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 7/27/2017 - 7 years ago
    33 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/27/2017 - 7 years ago
    32 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/8/2016 - 8 years ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/23/2016 - 8 years ago
    30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/23/2016 - 8 years ago
    29 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/3/2016 - 8 years ago
    28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/19/2016 - 8 years ago
    27 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 7/12/2016 - 8 years ago
    26 - ASSIGNED TO LIE Type: ALIE
  • 7/6/2016 - 8 years ago
    25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/21/2016 - 8 years ago
    24 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/21/2016 - 8 years ago
    23 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/16/2016 - 8 years ago
    22 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 12/31/2015 - 9 years ago
    21 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 12/31/2015 - 9 years ago
    20 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 12/31/2015 - 9 years ago
    19 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 12/9/2015 - 9 years ago
    18 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 5/27/2015 - 10 years ago
    17 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 12/29/2014 - 10 years ago
    16 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/19/2014 - 10 years ago
    15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 11/19/2014 - 10 years ago
    14 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 10/31/2014 - 10 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 4/23/2014 - 11 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/23/2014 - 11 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/23/2014 - 11 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/22/2014 - 11 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/21/2014 - 11 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/21/2014 - 11 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/5/2013 - 11 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/5/2013 - 11 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/5/2013 - 11 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/5/2013 - 11 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/26/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/26/2013 - 11 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP